title: [Treatment of chronic myeloid leukemia by recombinant alpha interferon and hydroxyurea].
authors.forename: F
authors.initials: F
authors.lastname: Guilhot
authors.forename: J
authors.initials: J
authors.lastname: Tanzer
authors.forename: A
authors.initials: A
authors.lastname: Brizard
authors.forename: B
authors.initials: B
authors.lastname: Dreyfus
authors.forename: J L
authors.initials: JL
authors.lastname: Huret
authors.forename: M C
authors.initials: MC
authors.lastname: Desmarest
authors.forename: S
authors.initials: S
authors.lastname: Briaut
mesh_terms: D000328:Adult; D000368:Aged; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D007370:Interferon Type I / Q000096:biosynthesis / Q000627:therapeutic use*; D007951:Leukemia, Myeloid / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000096:biosynthesis
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins; D006918:Hydroxyurea
vernacular_title: Traitement de la leucémie myéloïde chronique par interféron alpha recombinant et hydroxyurée.